Quad_Tech Profile Banner
Quad Technologies Profile
Quad Technologies

@Quad_Tech

Followers
143
Following
72
Media
44
Statuses
166

Revolutionizing translational medicine and cell therapy with a novel cell separation technology. Committed to enabling life via scientific innovation.

Boston MA
Joined February 2012
Don't wanna be here? Send us removal request.
@Quad_Tech
Quad Technologies
8 years
We are happy to have @SartoriusNA as our partner for Quickgel CD3/CD28 T-cell activation! https://t.co/Ut6Tq97Xm9
0
1
2
@bdplouffe
Brian Plouffe
8 years
As a former @MassChallenge finalist (Silver Winner 2013 with @Quad_Tech) and current BME assistant prof, welcome to @RegisCollege_MA Mike.
@RegisCollege_MA
Regis College
8 years
Join us in welcoming Michael LaRhette, MEd, President of @MassChallenge, to the Board of Trustees! Learn more about LaRhette's dedication to innovation and what he hopes to bring to the Board at https://t.co/VOiVobFRux
0
2
1
@Quad_Tech
Quad Technologies
8 years
Thanks Trish!
@trishnsiv
trishnsiv
8 years
Congrats @NSInnoVentures alum @Quad_Tech for their latest patent on T-Cell Activation Reagents. #innovation
0
0
0
@Quad_Tech
Quad Technologies
8 years
Check out what we're doing to improve the manufacturing of our product, QuickGel™: https://t.co/Tx5pJZo2Z7
0
3
2
@Quad_Tech
Quad Technologies
8 years
A great read!
@CIRMnews
California Institute for Regenerative Medicine
8 years
Researchers at @usponline & @UCSDHealth used induced pluripotent #stemcells to show for the 1st time that astrocytes – support cells for the nervous system – may play a role in #autism https://t.co/e9IzBvR2qw via @ElsevierNews
0
1
1
@Quad_Tech
Quad Technologies
8 years
We're revolutionizing gene cell therapy, and here's how!
0
0
0
@Quad_Tech
Quad Technologies
9 years
It's #NationalSuperheroDay . But in our case, not all superheroes wear capes! Our awesome R&D team wears lab coats, gloves, and goggles!
0
0
0
@Quad_Tech
Quad Technologies
9 years
It's reinvigorating!
@MSKCancerCenter
Memorial Sloan Kettering Cancer Center
9 years
Can we predict which patients will respond to anti-PD-1 #immunotherapy? Blood may hold the answer: https://t.co/kk5bWYP1rc
0
0
1
@Quad_Tech
Quad Technologies
9 years
Nice article on the future of manufacturing and commercialization of cell therapies. Thanks for sharing @PCTcelltherapy
@MinarisRM
Minaris Regenerative Medicine
9 years
PCT’s experts were recently interviewed by @GENbio on cell therapy manufacturing commercialization. Check it out at
0
0
0
@Quad_Tech
Quad Technologies
9 years
Awesome data! Congratulations @KitePharma
@KitePharma
Kite, a Gilead Company
9 years
Thanks @ #AACR17! If you missed us this year, you can find more information about ZUMA-1 data here: https://t.co/bkfDxBWJSM $Kite
0
0
0
@Quad_Tech
Quad Technologies
9 years
It's #worldhealthday2017 . At Quad, we strive every day to have #immunology play a significant role in cancer. What efforts are you doing?
0
0
1
@ASH_hematology
ASH
9 years
With 25%+ increases in survival for #leukemia, #NHLymphoma, & #myeloma, we are reminded why it is so important to #Fight4Hematology!
@NIH
NIH
9 years
News: Annual Report to the Nation: Cancer Death Rates Continue to Decline https://t.co/p2y1xow0dC #NIH #NIHnews
1
23
30
@Quad_Tech
Quad Technologies
9 years
We are excited to be a part of such a booming space! #CART #Tcells
@sitcancer
Society for Immunotherapy of Cancer
9 years
A multitude of SITC members featured in 'Cancer immunotherapy comes of age' https://t.co/bBSSHU9w1c via @sciencemagazine
0
1
2
@Quad_Tech
Quad Technologies
9 years
Great article on #breastcancer @scrippsresearch
@Labroots
Labroots
9 years
Antibodies are usually not potent enough to eradicate cancer https://t.co/DezLXogG4S
0
0
1
@Quad_Tech
Quad Technologies
9 years
Great results from @KitePharma on their ZUMA-1 clinical trial #Immunotherapy
0
1
1
@Quad_Tech
Quad Technologies
9 years
Read how #MagCloudz is enabling high purity isolation of #Bcells at @KingsCollegeLon : https://t.co/2FZSqtnDoh
0
1
1
@Quad_Tech
Quad Technologies
9 years
Discover the possibilities of new and innovative solutions for T cell activation and expansion: https://t.co/q4dbhQySOO
1
0
0
@Immuneadvisors
Immune Advisors
9 years
Successful #immunotherapy of two infants with hematological malignancy using CAR-T https://t.co/wnkicRdur2 ALLOGENEIC CELLS !! #leukemia
0
4
5
@Quad_Tech
Quad Technologies
9 years
MagCloudz streamlines your T Reg research with time-saving, multiple marker separation workflows: https://t.co/vrJbyvL0MI
0
0
0
@Quad_Tech
Quad Technologies
9 years
New MagCloudz CD8+ Scaled Isolation Method available #Tcell #MagCloudz
0
0
0